SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001193125-15-006530
Filing Date
2015-01-09
Accepted
2015-01-09 16:31:30
Documents
1
Group Members
ASTRAZENECA AB

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13G/A d845459dsc13ga.htm SC 13G/A 56122
  Complete submission text file 0001193125-15-006530.txt   57801
Mailing Address 2 KINGDOM STREET - LEGAL DEPARTMENT LONDON X0 W2 6BD
Business Address 2 KINGDOM STREET - LEGAL DEPARTMENT LONDON X0 W2 6BD 011 44 20 7304 5000
ASTRAZENECA PLC (Filed by) CIK: 0000901832 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: SC 13G/A
SIC: 2834 Pharmaceutical Preparations

Mailing Address 3545 JOHN HOPKINS COURT SUITE 210 SAN DIEGO CA 92121
Business Address 3545 JOHN HOPKINS COURT SUITE 210 SAN DIEGO CA 92121 858-202-6300
Regulus Therapeutics Inc. (Subject) CIK: 0001505512 (see all company filings)

IRS No.: 264738379 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-87002 | Film No.: 15519306
SIC: 2834 Pharmaceutical Preparations